← All stocks

Protagonist Therapeutics, Inc

PTGX Net selling

CIK 0001377121 #955 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$80.64M

$257.00K on a plan · $73.43M straight out of an exercise

Sold at will

$6.94M

8 of 37 sales

Net

−$80.64M

−$6.94M against sales at will

By person

9 insiders · 38 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

PATEL DINESH V PH D

President and CEO

—

$53.07M (13) scheduled

−$53.07M

522,968

0.8082%

$75.36M

+1.4%

Ali Asif

Chief Financial Officer

—

$7.32M (5) scheduled

−$7.32M

59,003

0.0912%

$8.50M

+64.6%

Giraudo Bryan

Director

—

$5.92M (4) scheduled

−$5.92M

12,695

0.0196%

$1.83M

−54.7%

Waddill William D.

Director

—

$5.84M (7) scheduled

−$5.84M

7,825

0.0121%

$1.13M

−34.8%

MOLINA ARTURO MD

Chief Medical Officer

—

$4.49M (6) scheduled

−$4.49M

84,115

0.1300%

$12.12M

+74.0%

SELICK HAROLD E

Director

—

$2.52M (1) scheduled

−$2.52M

60,845

0.0940%

$8.77M

+117.3%

Williams Lewis T

Director

—

$1.48M (1) scheduled

−$1.48M

7,825

0.0121%

$1.13M

—

Gupta Suneel

Chief Development Officer

—

267,433

0.4133%

$38.54M

+44.9%

O'Dowd Sarah A

Director

—

7,825

0.0121%

$1.13M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Waddill William D.

22 Sep 2025

Director

Sold on a plan

4,000

$64.25

$257.00K

Show all 38 transactions →

What was left out

Form 4 filings counted 36

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 28

Sales at will 8

Transactions with no price 0

Shares from compensation/vesting 850,522

History held since 15 Sep 2016